Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New glucose monitor could make skies safer for diabetic pilots

NCT ID NCT04225455

Knowledge-focused Sponsor: University of Surrey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a continuous glucose monitor (Dexcom G6) helps pilots with insulin-treated diabetes keep their blood sugar in a safe range during flights. Seventeen pilots wore the device for six months, comparing its readings with their usual finger-stick tests. The goal is to see if real-time monitoring improves safety and glucose control while flying.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

17 people

The number who actually took part.

Started

Dec 2019

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

30 pilots with class 1 and flying instructors or private pilots with class 2 medical certificates with insulin dependent diabetes

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 75 y inclusive. * Any ethnicity * Pilots requiring insulin replacement therapy * Pilots holding a class 1 or class 2 certificate * Pilots currently participating in the current scheme * Able and willing to perform self-blood glucose monitoring. * Able and willing to wear a Continuous Glucose Monitoring System (CGMS) for 6months Exclusion Criteria: * Outside of stated age range. * Those who are part of the protocol but are not flying currently.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insulin dependent diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insulin dependent diabetes

Contacts and locations

Locations

  • University of Surrey FHMS Nutritional Sciences

    Guildford, Surrey, GU2 7WG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.